| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |